What is the renal dosing for cefdinir in a patient with severe impaired renal function (eGFR of 25)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Renal Dosing for Cefdinir with eGFR of 25 mL/min

For patients with an eGFR of 25 mL/min, the recommended dose of cefdinir is 300 mg once daily instead of the standard 300 mg twice daily regimen. 1

Dosing Rationale and Evidence

The FDA-approved drug labeling for cefdinir clearly states that for adult patients with creatinine clearance <30 mL/min, the dose should be reduced to 300 mg given once daily 1. This represents a 50% reduction from the standard adult dose of 300 mg twice daily.

For pediatric patients with creatinine clearance <30 mL/min/1.73 m², the dose should be reduced to 7 mg/kg (up to a maximum of 300 mg) given once daily 1.

Special Considerations for Hemodialysis

If your patient with eGFR of 25 mL/min is also on hemodialysis, the dosing regimen changes:

  • Initial dose: 300 mg (or 7 mg/kg for pediatric patients)
  • Dosing frequency: Every other day
  • Post-dialysis: Administer 300 mg (or 7 mg/kg) at the conclusion of each hemodialysis session
  • Subsequent doses: Continue with 300 mg (or 7 mg/kg) every other day 1

Pharmacokinetic Considerations

The elimination half-life of cefdinir is significantly prolonged in patients with renal impairment. Studies have shown:

  • Normal renal function: ~1.7 hours
  • Severe renal impairment: ~16-17 hours 2

This extended half-life necessitates the dosage reduction to prevent drug accumulation and potential toxicity.

Monitoring Recommendations

When administering cefdinir to patients with eGFR of 25 mL/min:

  • Monitor renal function regularly
  • Watch for signs of neurotoxicity (altered mental status, confusion, seizures)
  • Be vigilant for superinfection, especially with resistant organisms
  • Consider therapeutic drug monitoring if available, particularly for prolonged therapy

Potential Adverse Effects in Renal Impairment

Patients with renal impairment may be at higher risk for:

  • Drug accumulation leading to toxicity
  • Acute tubulointerstitial nephritis (rare but reported with cefdinir) 3
  • Neurotoxicity (more commonly reported with other cephalosporins like cefepime, but possible with cefdinir) 4

Conclusion

For a patient with an eGFR of 25 mL/min, cefdinir should be dosed at 300 mg once daily. If the patient is on hemodialysis, the dosing should be adjusted to 300 mg every other day with an additional dose after each dialysis session.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.